Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 20 October 2006:
Vol. 314. no. 5798, pp. 467 - 471
DOI: 10.1126/science.1130276
Prev | Table of Contents | Next

Reports

S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth

N. Valerio Dorrello,1* Angelo Peschiaroli,1* Daniele Guardavaccaro,1 Nancy H. Colburn,2 Nicholas E. Sherman,3 Michele Pagano1{dagger}

The tumor suppressor programmed cell death protein 4 (PDCD4) inhibits the translation initiation factor eIF4A, an RNA helicase that catalyzes the unwinding of secondary structure at the 5' untranslated region (5'UTR) of messenger RNAs (mRNAs). In response to mitogens, PDCD4 was rapidly phosphorylated on Ser67 by the protein kinase S6K1 and subsequently degraded via the ubiquitin ligase SCFßTRCP. Expression in cultured cells of a stable PDCD4 mutant that is unable to bind ßTRCP inhibited translation of an mRNA with a structured 5'UTR, resulted in smaller cell size, and slowed down cell cycle progression. We propose that regulated degradation of PDCD4 in response to mitogens allows efficient protein synthesis and consequently cell growth.

1 Department of Pathology, NYU Cancer Institute, New York University School of Medicine, 550 First Avenue, MSB 599, New York, NY 10016, USA.
2 Laboratory of Cancer Prevention, National Cancer Institute, Building 576, Frederick, MD 21702, USA.
3 W. M. Keck Biomedical Mass Spectrometry Lab, University of Virginia, Charlottesville, VA 22908, USA.

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: michele.pagano{at}med.nyu.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
{beta}-TrCP-Mediated Ubiquitination and Degradation of PHLPP1 Are Negatively Regulated by Akt.
X. Li, J. Liu, and T. Gao (2009)
Mol. Cell. Biol. 29, 6192-6205
   Abstract »    Full Text »    PDF »
c-Myc and eIF4F Constitute a Feedforward Loop That Regulates Cell Growth: Implications for Anticancer Therapy.
C.-J. Lin, A. Malina, and J. Pelletier (2009)
Cancer Res. 69, 7491-7494
   Abstract »    Full Text »    PDF »
Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction.
M. Yasuda, T. Nishizawa, H. Ohigashi, T. Tanaka, D.-X. Hou, N. H. Colburn, and A. Murakami (2009)
Carcinogenesis 30, 1209-1216
   Abstract »    Full Text »    PDF »
Silibinin inhibits translation initiation: implications for anticancer therapy.
C.-J. Lin, R. Sukarieh, and J. Pelletier (2009)
Mol. Cancer Ther. 8, 1606-1612
   Abstract »    Full Text »    PDF »
Interferon-Dependent Engagement of Eukaryotic Initiation Factor 4B via S6 Kinase (S6K)- and Ribosomal Protein S6K-Mediated Signals.
B. Kroczynska, S. Kaur, E. Katsoulidis, B. Majchrzak-Kita, A. Sassano, S. C. Kozma, E. N. Fish, and L. C. Platanias (2009)
Mol. Cell. Biol. 29, 2865-2875
   Abstract »    Full Text »    PDF »
mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells.
J. Zhou, P. Su, L. Wang, J. Chen, M. Zimmermann, O. Genbacev, O. Afonja, M. C. Horne, T. Tanaka, E. Duan, et al. (2009)
PNAS 106, 7840-7845
   Abstract »    Full Text »    PDF »
MicroRNA involvement in the pathogenesis and management of breast cancer.
S M Khoshnaw, A R Green, D G Powe, and I O Ellis (2009)
J. Clin. Pathol. 62, 422-428
   Abstract »    Full Text »    PDF »
The Pharmacology of mTOR Inhibition.
D. A. Guertin and D. M. Sabatini (2009)
Science Signaling 2, pe24
   Abstract »    Full Text »    PDF »
Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment.
K. Inoki and K.-L. Guan (2009)
Hum. Mol. Genet. 18, R94-R100
   Abstract »    Full Text »    PDF »
Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth.
M. Shiota, H. Izumi, A. Tanimoto, M. Takahashi, N. Miyamoto, E. Kashiwagi, A. Kidani, G. Hirano, D. Masubuchi, Y. Fukunaka, et al. (2009)
Cancer Res. 69, 3148-3156
   Abstract »    Full Text »    PDF »
S6 Kinase 1 Regulates Estrogen Receptor {alpha} in Control of Breast Cancer Cell Proliferation.
R. L. Yamnik, A. Digilova, D. C. Davis, Z. N. Brodt, C. J. Murphy, and M. K. Holz (2009)
J. Biol. Chem. 284, 6361-6369
   Abstract »    Full Text »    PDF »
Crystal structure of the eIF4A-PDCD4 complex.
J. H. Chang, Y. H. Cho, S. Y. Sohn, J. M. Choi, A. Kim, Y. C. Kim, S. K. Jang, and Y. Cho (2009)
PNAS 106, 3148-3153
   Abstract »    Full Text »    PDF »
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation.
A. Y. Choo, S.-O. Yoon, S. G. Kim, P. P. Roux, and J. Blenis (2008)
PNAS 105, 17414-17419
   Abstract »    Full Text »    PDF »
Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division.
D. Michaelson, W. Abidi, D. Guardavaccaro, M. Zhou, I. Ahearn, M. Pagano, and M. R. Philips (2008)
J. Cell Biol. 181, 485-496
   Abstract »    Full Text »    PDF »
Tumorigenic activity and therapeutic inhibition of Rheb GTPase.
K. J. Mavrakis, H. Zhu, R. L.A. Silva, J. R. Mills, J. Teruya-Feldstein, S. W. Lowe, W. Tam, J. Pelletier, and H.-G. Wendel (2008)
Genes & Dev. 22, 2178-2188
   Abstract »    Full Text »    PDF »
mTORC1 promotes survival through translational control of Mcl-1.
J. R. Mills, Y. Hippo, F. Robert, S. M. H. Chen, A. Malina, C.-J. Lin, U. Trojahn, H.-G. Wendel, A. Charest, R. T. Bronson, et al. (2008)
PNAS 105, 10853-10858
   Abstract »    Full Text »    PDF »
Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma.
J. Woodard, A. Sassano, N. Hay, and L. C. Platanias (2008)
Clin. Cancer Res. 14, 4640-4649
   Abstract »    Full Text »    PDF »
c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation.
C.-J. Lin, R. Cencic, J. R. Mills, F. Robert, and J. Pelletier (2008)
Cancer Res. 68, 5326-5334
   Abstract »    Full Text »    PDF »
Suppression of Programmed Cell Death 4 (PDCD4) Protein Expression by BCR-ABL-regulated Engagement of the mTOR/p70 S6 Kinase Pathway.
N. Carayol, E. Katsoulidis, A. Sassano, J. K. Altman, B. J. Druker, and L. C. Platanias (2008)
J. Biol. Chem. 283, 8601-8610
   Abstract »    Full Text »    PDF »
PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains.
C. Suzuki, R. G. Garces, K. A. Edmonds, S. Hiller, S. G. Hyberts, A. Marintchev, and G. Wagner (2008)
PNAS 105, 3274-3279
   Abstract »    Full Text »    PDF »
Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion.
T. Schmid, A. P. Jansen, A. R. Baker, G. Hegamyer, J. P. Hagan, and N. H. Colburn (2008)
Cancer Res. 68, 1254-1260
   Abstract »    Full Text »    PDF »
Regulatory Effects of Mammalian Target of Rapamycin-mediated Signals in the Generation of Arsenic Trioxide Responses.
J. K. Altman, P. Yoon, E. Katsoulidis, B. Kroczynska, A. Sassano, A. J. Redig, H. Glaser, A. Jordan, M. S. Tallman, N. Hay, et al. (2008)
J. Biol. Chem. 283, 1992-2001
   Abstract »    Full Text »    PDF »
Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells.
L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund (2008)
J. Biol. Chem. 283, 1026-1033
   Abstract »    Full Text »    PDF »
Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity.
M. D. Antion, M. Merhav, C. A. Hoeffer, G. Reis, S. C. Kozma, G. Thomas, E. M. Schuman, K. Rosenblum, and E. Klann (2008)
Learn. Mem. 15, 29-38
   Abstract »    Full Text »    PDF »
FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases.
Y. G. Ni, N. Wang, D. J. Cao, N. Sachan, D. J. Morris, R. D. Gerard, M. Kuro-o, B. A. Rothermel, and J. A. Hill (2007)
PNAS 104, 20517-20522
   Abstract »    Full Text »    PDF »
A Novel Function of eIF2{alpha} Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway.
S. Kazemi, Z. Mounir, D. Baltzis, J. F. Raven, S. Wang, J.-L. Krishnamoorthy, O. Pluquet, J. Pelletier, and A. E. Koromilas (2007)
Mol. Biol. Cell 18, 3635-3644
   Abstract »    Full Text »    PDF »
SCFFbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins.
L. Busino, F. Bassermann, A. Maiolica, C. Lee, P. M. Nolan, S. I. H. Godinho, G. F. Draetta, and M. Pagano (2007)
Science 316, 900-904
   Abstract »    Full Text »    PDF »
Exploring Translation Initiation as a Chemotherapeutic Target.
J. Pelletier (2007)
Am. Assoc. Cancer Res. Educ. Book 2007, 147-152
   Full Text »    PDF »
Nuclear Factor-{kappa}B Accounts for the Repressor Effects of High Stromal Cell-Derived Factor-1{alpha} Levels on Tac1 Expression in Nontumorigenic Breast Cells.
K. E. Corcoran and P. Rameshwar (2007)
Mol. Cancer Res. 5, 373-381
   Abstract »    Full Text »    PDF »
Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4.
N. LaRonde-LeBlanc, A. N. Santhanam, A. R. Baker, A. Wlodawer, and N. H. Colburn (2007)
Mol. Cell. Biol. 27, 147-156
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)